Frontiers | Pulmonary Fibrosis and Lung Carcinogenesis: Do Myofibroblasts and Cancer-associated Fibroblasts Share a Common Identity?

Pulmonary Fibrosis and Lung Carcinogenesis: Do Myofibroblasts and Cancer-associated Fibroblasts Share a Common Identity?

5,171
Total downloads
16k
Total views and downloads

Articles

EDITORIAL

Published on 11 Mar 2024

Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?

Daniela de Totero
Emanuela Barisione
Enrico Clini

doi 10.3389/fonc.2024.1389532

788 views

ORIGINAL RESEARCH

Published on 23 Jan 2024

Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis

Anna Valeria Samarelli
Roberto Tonelli
Giulia Raineri
Giulia Bruzzi
Dario Andrisani
Filippo Gozzi
Alessandro Marchioni
Matteo Costantini
Luca Fabbiani
12 more
Stefania Cerri

Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis

doi 10.3389/fonc.2023.1275346

1,912 views
1 citation

SYSTEMATIC REVIEW

Published on 11 Oct 2023

Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis

Zhen Wang
Jiayu Bai
Yujia Liu
Peng Li
Guangyu Jiao

Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis

doi 10.3389/fonc.2023.1250688

1,208 views
2 citations

REVIEW

Published on 25 Sep 2023

Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions

Priyanka Sahu
Chantal Donovan
Keshav Raj Paudel
Sophie Pickles
Vrushali Chimankar
Richard Y. Kim
Jay C. Horvart
Kamal Dua
Antonio Ieni
5 more
Philip M. Hansbro

Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions

doi 10.3389/fonc.2023.1260411

2,570 views
6 citations

ORIGINAL RESEARCH

Published on 12 Jul 2023

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer

Qiyu Fang
Xiaoying Wan
Angelica D’Aiello
Hui Sun
Weiquing Gu
Yixue Li
Caicun Zhou
Boxiong Xie
Qinfang Deng
1 more
Songwen Zhou

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer

doi 10.3389/fonc.2023.1116809

1,197 views
1 citation

ORIGINAL RESEARCH

Published on 05 Jul 2023

A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape

Lingjun Dong
Linhai Fu
Ting Zhu
Yuanlin Wu
Zhupeng Li
Jianyi Ding
Jiandong Zhang
Xiang Wang
Junjun Zhao
Guangmao Yu

A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape

doi 10.3389/fonc.2023.1180723

2,419 views
3 citations

ORIGINAL RESEARCH

Published on 16 Jun 2023

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer

Helen F. Titmarsh
Alex von Kriegsheim
Jimi C. Wills
Richard A. O’Connor
Kevin Dhaliwal
Margaret C. Frame
Samuel B. Pattle
David A. Dorward
Adam Byron
Ahsan R. Akram

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer

doi 10.3389/fonc.2023.1194515

2,102 views
5 citations

ORIGINAL RESEARCH

Published on 05 Jun 2023

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

Ningning Li
Liwei Gao
Chunmei Bai
Lin Zhao
Yajuan Shao

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

doi 10.3389/fonc.2023.1167213

1,035 views
2 citations

Share on

Frontiers in Oncology

Frontiers in Oncology

Thoracic Oncology

Impact

16kTopic views
10kArticle views
5,171Article downloads